rmdaTenth of Ramadan Pharmaceutical Industries & Diagnostic-RamedaEGX_DLY:RMDAQQQQ9999Technical Analysis — El-Nile Co. for Pharmaceuticals & Chemical Industries — Weekly Chart The stock is in a very strong bullish trend. Price has moved from a long accumulation phase below EGP 40 into a sharp parabolic rally, now trading around EGP 310, with the current weekly candle showing a strong gain of about +38%. Trend Status The major trend is clearly bullish, supported by a sequence of strong breakout candles and expanding momentum. The move from the 90–110 area to above 300 was very aggressive, suggesting strong demand and possible speculative momentum. PRZ / Target Zone The highlighted green area around EGP 310–350 acts as a Potential Reversal Zone (PRZ). Price has already entered this zone, so the stock is now in a sensitive area. This does not automatically mean sell, but it means the risk of short-term exhaustion is increasing, especially after such a vertical move. Key Resistance Levels The main resistance zone is: 310 – 350 EGP A weekly close above 350 would confirm continuation strength and may open the way toward: 370 – 400 EGP Key Support Levels Important support areas are: 300 – 310: immediate support / current breakout area 240 – 250: first strong pullback support 200 – 220: secondary support 160: major trend support 100 – 110: previous consolidation base Momentum Reading The move is extremely powerful, but also overextended. Vertical rallies often continue longer than expected, but they also carry a higher risk of sharp corrections once momentum slows. A warning signal would appear if the stock forms: a long upper wick inside the PRZ, a bearish engulfing candle, a weekly close below 300, or strong volume with failure to continue above 350. Trading View For holders, the chart supports profit protection or partial profit-taking inside the 310–350 zone. For new buyers, the risk is high at the current level. A safer entry would usually come either after a breakout above 350 with confirmation, or after a pullback toward support. Summary The chart is strongly bullish, but price is now inside a potential exhaustion / reversal zone. The best technical approach is to treat 310–350 as a decision area: continuation above 350 is bullish, while failure below 300 may trigger a correction toward 240–250. Today 5:32 AM Technical Analysis — Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda — Weekly Chart The stock is in a strong bullish trend after breaking out from a long accumulation/consolidation phase. Price is currently trading around EGP 6.35, near the upper end of the marked target zone. Trend Structure The chart shows three clear phases: Long accumulation phase between roughly EGP 0.90 – 1.60. First bullish expansion toward the EGP 3.00 – 3.40 area. Bullish continuation breakout from a flag/triangle structure around EGP 3.00 – 3.30, followed by a sharp rally toward EGP 6.35 – 6.50. The breakout above EGP 3.30 – 3.50 was very important, and the stock has already delivered a strong measured move from that breakout. Key Resistance The immediate resistance is around: EGP 6.50 – 6.70 This is the current upper resistance zone. Price is very close to it, and the black horizontal line on the chart suggests that this area may act as a short-term profit-taking zone. A strong weekly close above EGP 6.70 could open the way toward: EGP 7.20 – 7.50 and possibly EGP 8.00 if momentum remains strong. Key Supports Important support levels are: EGP 5.00 – 5.10 This is the first important support and the recent breakout/consolidation area. EGP 4.35 – 4.50 This area aligns with the 20-week moving average, making it a dynamic support. EGP 3.20 – 3.30 This is the major breakout base. Losing this level would weaken the bullish structure. RSI RSI is around 82, which means the stock is strong but overbought. This does not mean the stock must fall immediately, but it does mean the risk of a short-term correction or sideways consolidation is increasing. MACD MACD remains bullish. The MACD line is above the signal line, and momentum is expanding again. This supports continuation, but the move is already stretched. Trading View For holders, the trend remains positive as long as price stays above EGP 5.00. Partial profit-taking near 6.50 – 6.70 may be reasonable because the stock is extended. For new buyers, the current level is risky because price is near resistance and RSI is overbought. A safer setup would be either: A pullback toward 5.00 – 5.10, then bullish reaction, or a confirmed weekly breakout above 6.70. Summary The chart is bullish, but price is now near a short-term resistance and overbought zone. The main decision area is EGP 6.50 – 6.70. A breakout above it confirms continuation, while failure there may trigger a pullback toward EGP 5.00 – 5.10.